Cognitive impairment resulting from the radiotherapeutic management of brain tumors represents a clinically intractable condition that adversely impacts quality of life. The capability to critically evaluate potential interventions for ameliorating radiation-induced cognitive decrements ultimately depends on the capability to undertake rigorous quantitative assessments of cognition.
Christie, L. A., Acharya, M. M., Limoli, C. L. Quantifying Cognitive Decrements Caused by Cranial Radiotherapy. J. Vis. Exp. (56), e3108, doi:10.3791/3108 (2011).